Press Releases - 2022-06-30
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
Wholly Owned Pipeline - LYT-200
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
Press Releases - 2022-06-28
PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
Press Releases - 2022-06-21
PureTech Founded Entity Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million
Press Releases - 2022-06-14
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-300
Wholly Owned Pipeline - Technology Platforms
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
Press Releases - 2022-06-14
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute "Long" COVID with Respiratory Complications
Press Releases - 2022-06-06
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
Press Releases - 2022-06-06
PureTech Founded Entity Gelesis Presents Study of Proprietary Hydrogel That Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects
